Amane Sasada

Papers

1

Total Citations

3

H-Index

1

About

Amane Sasada is a clinical researcher whose work focuses on the intersection of immunotherapy and oncology, particularly in the treatment of advanced gastrointestinal cancers. His most notable contribution is a pioneering case report from 2015, which describes a 62-year-old patient with stage IV gastric cancer who achieved complete remission after receiving multi-peptide dendritic cell immunotherapy in combination with standard therapies. This study targeted four key cancer antigens—WT1, MUC1, Her-2, and survivin—and demonstrated the potential of personalized, multi-targeted immune strategies to overcome the challenges of late-stage disease. Although the paper has accumulated only 3 citations, its significance lies in its proof-of-concept for integrating dendritic cell vaccines with conventional chemotherapy, offering a glimpse into future combinatorial treatments. Sasada’s work underscores the promise of harnessing the immune system to achieve durable responses in cancers traditionally considered incurable. His research continues to inspire efforts in developing more effective, patient-specific immunotherapies for solid tumors.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
A patient with stage IV gastric cancer who acquired complete remission after undergoing multi-peptide dendritic cell immunotherapy in combination with standard therapies
3 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 4

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago